| 1 | Approve Consolidated and Standalone Financial Statements
| Abstain |
| 2 | Approve Non-Financial Statements | Abstain |
| 3 | Approve Treatment of Net Loss
| For |
| 4 | Discharge the Board | Abstain |
| 5.1 | Approve Fees Payable to the Board of Directors | For |
| 5.2 | Approve Remuneration Policy | Abstain |
| 5.3 | Approve Grant of Shares to CEO
| For |
| 6.1 | Set the Number of Board Directors | For |
| 6.2 | Re-Elect Tobías Martínez Gimeno - Chief Executive | For |
| 6.3 | Re-Elect Bertrand Kan - Chair (Non Executive) | For |
| 6.4 | Re-Elect Pierre Blayau - Non-Executive Director | For |
| 6.5 | Re-Elect Anne Bouverot - Non-Executive Director | For |
| 6.6 | Re-Elect Maria Luisa Guijarro Pinal - Non-Executive Director | For |
| 6.7 | Elect Leonard Peter Shore - Non-Executive Director | For |
| 6.8 | Elect Kate Holgate - Non-Executive Director | For |
| 7.1 | Amend Article 4: Corporate Website
| For |
| 7.2 | Amend Article 18: Board Term
| For |
| 7.3 | Amend Article 20: Director Remuneration
| For |
| 7.4 | Approve Restated Articles of Association
| For |
| 8 | Approve Exchange of Debt for Equity
| For |
| 9 | Authorize Increase in Capital up to 50 Percent via Issuance of Equity or Equity-Linked Securities, Excluding Preemptive Rights of up to 10 Percent
| For |
| 10 | Authorize Issuance of Convertible Bonds, Debentures, Warrants, and Other Debt Securities with Exclusion of Preemptive Rights up to 10 Percent of Capital
| Oppose |
| 11 | Authorize Board to Ratify and Execute Approved Resolutions
| For |
| 12 | Approve the Remuneration Report | Abstain |
